Perceptive Advisors’s Repros Therapeutics RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-220,000
Closed -$1.64M – 198
2015
Q3
$1.64M Buy
+220,000
New +$1.68M 0.13% 86
2014
Q1
– Sell
-71,879
Closed -$1.32M – 166
2013
Q4
$1.32M Sell
71,879
-1,409,854
-95% -$26.6M 0.16% 63
2013
Q3
$39.7M Buy
1,481,733
+1,300,303
+717% +$27.9M 3.22% 9
2013
Q2
$3.35M Buy
+181,430
New +$3.2M 0.34% 40

Other funds holding RPRX

Perceptive Advisors's RPRX Position: Q4 2015 in Review

Perceptive Advisors sold out of Repros Therapeutics (RPRX) in Q4 2015, closing a stake of 220,000 shares — an estimated $1.64M sold.

Perceptive Advisors first reported a position in RPRX in Q2 2013 and held it in 4 quarters. The position peaked at $39.7M in Q3 2013. 56 funds tracked by Wall St. Rank hold RPRX as of Q4 2015.

  • Perceptive Advisors reported no remaining Repros Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Perceptive Advisors sold 220,000 Repros Therapeutics shares in Q4 2015, an estimated $1.64M.
  • Perceptive Advisors first reported a position in Repros Therapeutics in Q2 2013 and held it in 4 quarters.
  • Perceptive Advisors's Repros Therapeutics position peaked at $39.7M in Q3 2013.
  • 56 funds tracked by Wall St. Rank held Repros Therapeutics as of Q4 2015.

Based on Perceptive Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.